Bertelsmann Investments (BI) invests a mid-single-digit million Euro amount in Author-it Software Corporation (ASC), world leader in component-based authoring solutions and service provider for pharmaceutical companies based in New Zealand. ASC is the developer behind Docuvera, a platform within the Life Sciences sector.
Bertelsmann Investments (BI) invests a mid-single-digit million Euro amount in Author-it Software Corporation (ASC), world leader in component-based authoring solutions and service provider for pharmaceutical companies based in New Zealand. ASC is the developer behind Docuvera, a platform within the Life Sciences sector.
Introducing Docuvera – Software to create Life Science documentation that lowers cost and increases compliance
Pharmaceutical company Boehringer Ingelheim selects Docuvera to enable medical authors to efficiently build clinical and regulatory documents from pre-approved components of medical content.
